Original Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Mar 21, 2009; 15(11): 1331-1338
Published online Mar 21, 2009. doi: 10.3748/wjg.15.1331
Table 1 Frequencies of clinical manifestations related to the degree of histological severity
Normal mucosa (Marsh 0) n = 6 (%)LE (Marsh I) n = 9 (%)Atrophy (Marsh III) n = 6 (%)Pvalue
Flatulence4 (66.7)6 (66.7)4 (66.7)1
Distension2 (33.4)7 (77.8)4 (66.7)0.282
Abdominal pain0 (0.0)6 (66.7)4 (66.7)0.029
Diarrhea1 (16.7)4 (44.5)4 (66.7)0.300
Asthenia2 (33.4)2 (22.3)4 (66.7)0.213
Anemia0 (0)0 (0)1 (16.7)0.571
Hypertransaminasemia1 (16.7)1 (11.9)2 (33.3)0.783
Table 2 Relationship between the values of VAS and degree of histological damage
Normal mucosa (Marsh 0) n = 6LE (Marsh I) n = 9Atrophy (Marsh III) n = 6Pvalue
Flatulence36.6 ± 12.0 (0-60)28.8 ± 8.2 (0-60)36.6 ± 14.7 (0-80)0.839
Distension6.67 ± 4.2 (0-20)28.8 ± 6.7 (0-60)50.0 ± 16.9 (0-100)0.035
Abdominal pain0.0 ± 0.0 (0-20)31.1 ± 10.0 (0-80)26.6 ± 9.8 (0-60)0.06
Diarrhea8.33 ± 8.3 (0-50)17.7 ± 9.1 (0-80)30.0 ± 12.3 (0-80)0.384
Asthenia10.0 ± 6.8 (0-40)11.1 ± 7.5 (0-60)50.0 ± 16.9 (0-100)0.031
Table 3 Follow-up of patients who adhered to GFD
At basal evaluation
After GFD
Clinical featuresEmAtTGA (U/mL)BiopsyIELsClinical featuresEmAtTGA (U/mL)BiopsyIELs
Case 1 female 47 yearsFlatulence, distension, abdominal pain, diarrhea, asthenia, anemia, osteopenia> 1/16074Marsh IIIb---AstheniaNeg.3.3Marsh I35%
Case 2 female 24 yearsFlatulence> 1/160159Marsh IIIb---No symptomsNeg.1.9------
Case 3 male 41 yearsFlatulence, distension, abdominal pain, diarrhea, asthenia, hypertransaminasemia> 1/16063.4Marsh IIIc---Asthenia, hypertransaminasemiaNeg.2.0Marsh I28%
Case 4 female 32 yearsOsteopenia1/808.5Marsh IIIa---OsteopeniaNeg.0------
Case 5 female 22 yearsDistension, abdominal pain, diarrhea, asthenia, hypertransaminasemia, osteopenia1/104.34Marsh IIIb---Distension, osteopeniaNeg.1.0Marsh I42%
Case 6 female 42 yearsFlatulence, distension, osteopeniaNeg.2.0Marsh I40%OsteopeniaNeg.2.4Marsh 022%
Case 7 male 41 yearsOsteopeniaNeg.3.34Marsh I26%No symptomsNeg.1.24Marsh I26%
Case 8 female 38 yearsFlatulence, distension, abdominal painNeg.4.04Marsh I42%FlatulenceNeg.2.0Marsh 017%
Case 9 male 37 yearsDistension, abdominal pain, diarrhea, osteopeniaNeg.3.20Marsh I26%Abdominal pain, diarrhea, osteopeniaNeg.2.4Marsh I28%
Case 10 male 32 yearsFlatulence, distension, abdominal pain, diarrhea, asthenia, osteopeniaNeg.2.34Marsh I35%Flatulence, distension, abdominal pain, diarrhea, asthenia, osteopeniaNeg.1Marsh 014%
Table 4 Evolution of symptoms after 1 year of follow-up for those patients who adhered to a GFD (n = 10; 5 Marsh I, 5 Marsh III)
Basal (mean values of VAS)After 1 year of GFD (mean values of VAS)Pvalue
Flatulence28 ± 8.95 ± 3.40.028
Distension42 ± 10.97 ± 4.70.014
Abdominal pain28 ± 9.07 ± 5.10.007
Diarrhea24 ± 10.24 ± 2.60.063
Asthenia28 ± 12.312 ± 6.60.133
Table 5 Patients who accepted follow-up but did not adhere to GFD
At basal evaluation
Follow-up
Clinical featuresEmAtTGA (U/mL)BiopsyIELsClinical featuresEmAtTGA (U/mL)BiopsyIELs
Case 1 male 23 yearsFlatulence, distension, abdominal pain, diarrhea, asthenia1/406.76Marsh IIIb----Flatulence, distension, abdominal pain, diarrhea, astheniaNeg.1.70Not accepted---
Case 2 male 63 yearsOsteopeniaNeg.4.07Marsh I29%OsteopeniaNeg.2.2Marsh I25%
Case 3 male 24 yearsFlatulence, distension, abdominal pain, diarrhea, astheniaNeg.3.47Marsh I25%Flatulence, distension, diarrhea, astheniaNeg.1.0Not accepted---
Case 4 female 66 yearsFlatulence, distension, abdominal painNeg.5.60Marsh I35%Diarrhea, abdominal pain, distension, flatulenceNeg.15Marsh IIIa---
Case 5 male 45 yearsAstheniaNeg.2.68Marsh 05%AstheniaNeg.2.0Marsh I28%
Case 6 male 47 yearsFlatulenceNeg.3.95Marsh 022%FlatulenceNeg.1.0Marsh 05%
Case 7 male 36 yearsDistensionNeg.2.78Marsh 020%Distension, hypertransaminasemiaNeg.1.2Not accepted---
Case 8 male 36 yearsFlatulenceNeg.2.80Marsh 018%FlatulenceNeg.1.0Not accepted---